Showing results (81-90 of 91) with videos related to
Sort By:
Pageof 10
The Journal of Thoracic and Cardiovascular Surgery|August 16, 2011
Effect of hiatal hernia size and columnar segment length on the success of radiofrequency ablation for Barrett's esophagus: a single-center, phase II clinical trialRobert J Korst, Sobeida Santana-Joseph, John R Rutledge, et al.The Journal of Thoracic and Cardiovascular Surgery|December 11, 2012
Patterns of recurrent and persistent intestinal metaplasia after successful radiofrequency ablation of Barrett's esophagusRobert J Korst, Sobeida Santana-Joseph, John R Rutledge, et al.The Journal of Biological Chemistry|October 2, 2008
SCCRO (DCUN1D1) is an essential component of the E3 complex for neddylationAlexander Y Kim, Claire C Bommeljé, Benjamin E Lee, et al.Science Translational Medicine|March 16, 2022
Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non-small cell lung cancerErik Wennerberg, Sumit Mukherjee, Sheila Spada, et al.The Journal of Thoracic and Cardiovascular Surgery|October 12, 2024
Initial patient characteristics of Thoracic Surgical Oncology Group 102: A multicenter prospective registry of active surveillance in patients with multiple ground-glass opacitiesJames Huang, Kay See Tan, Nasser Altorki, et al.The Lancet. Oncology|May 2, 2016
Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trialJohan F Vansteenkiste, Byoung Chul Cho, Tonu Vanakesa, et al.The Lancet. Oncology|May 20, 2021
Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trialNasser K Altorki, Timothy E McGraw, Alain C Borczuk, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 13, 2023
International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant TherapySanja Dacic, William Travis, Mary Redman, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 2, 2026
Machine learning assessment of pathologic response in lung cancer resections after neoadjuvant therapy - IASLC MPR ProjectSanja Dacic, Daniel Shenker, Mary Redman, et al.Nature Communications|December 19, 2023
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trialNasser K Altorki, Zachary H Walsh, Johannes C Melms, et al.Pageof 10